AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimizest MV 1mg/500mg/0.2mg Tablet

Prescription Icon
Prescription Required

Marketer

Alniche Life Sciences Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)

Overview Glimizest MV 1mg/500mg/0.2mg Tablet

Glimizest MV 1mg/500mg/0.2mg tablets are classified as antidiabetic medications, a combination therapy for adult-onset type 2 diabetes. This medication helps regulate blood glucose in diabetic patients. Administer Glimizest MV with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar or feeling well; abrupt cessation can elevate blood glucose, increasing the risk of complications like kidney damage, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect; familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and treatment. Maintain regular meals and carry readily available glucose sources like sugary snacks or juice. Alcohol consumption should be limited due to increased hypoglycemia risk. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Glimizest MV 1mg/500mg/0.2mg Tablet

Managing type 2 diabetes

Major Benefits of Glimizest MV 1mg/500mg/0.2mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimizest MV 1mg/500mg/0.2mg Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.

Common Side effects of Glimizest MV 1mg/500mg/0.2mg Tablet:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Glimizest MV 1mg/500mg/0.2mg Tablet:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimizest MV 1mg/500mg/0.2mg tablets should be administered on an empty stomach.

How Glimizest MV 1mg/500mg/0.2mg Tablet works:

One tablet of Glimizest MV (1mg/500mg/0.2mg) combines three medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimizest MV 1mg/500mg/0.2mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimizest MV 1mg/500mg/0.2mg Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any risks before prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glimizest MV 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Glimizest MV 1mg/500mg/0.2mg Tablets due to potential safety concerns. Medical advice is recommended. This medication is especially inadvisable for individuals with severe kidney impairment.

LiverLiverCAUTION

Patients with liver impairment should use Glimizest MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dose modification. Individuals with mild to moderate liver disease should begin with a low dose; however, use is contraindicated in those with severe liver dysfunction. Consult your physician for guidance.

What if you forget to take Glimizest MV 1mg/500mg/0.2mg Tablet :

Should you forget a Glimizest MV 1mg/500mg/0.2mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimizest MV 1mg/500mg/0.2mg Tablet

LabelValue
Potential for Dependence None.
Medication Category Medication for diabetes

FAQs on Glimizest MV 1mg/500mg/0.2mg Tablet

Glimizest MV 1mg/500mg/0.2mg tablets contain glimepiride, metformin, and voglibose. This triple-drug formulation manages type 2 diabetes mellitus in adults. Effective blood sugar control requires concurrent dietary modification and physical activity. Glimepiride enhances pancreatic insulin secretion, reducing blood glucose. Metformin decreases hepatic glucose production and increases insulin responsiveness. Voglibose, an alpha-glucosidase inhibitor, reduces post-meal blood sugar elevations. This medication is unsuitable for type 1 diabetes.
Glimizest MV 1mg/500mg/0.2mg tablets may cause common adverse reactions including low blood glucose, nausea, diarrhea, taste disturbances, gas, abdominal pain, headache, skin eruptions, and respiratory infections.
Patients with hypersensitivity to any constituent or inactive ingredient in Glimizest MV 1mg/500mg/0.2mg Tablet should not take this medication. Its administration is contraindicated in individuals with moderate to severe renal impairment, inflammatory bowel disorders, colonic ulcers, and pre-existing metabolic acidosis, encompassing diabetic ketoacidosis.
Combining Glimizest MV 1mg/500mg/0.2mg tablets and alcohol is unsafe. This combination can lead to dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Indeed, Glimizest MV 1mg/500mg/0.2mg Tablets may induce hypoglycemia. Low blood sugar symptoms encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of unease or tremor. This risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Retain this medication within its original, sealed packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Glimizest MV 1mg/500mg/0....
89
MRP 109
18% off